Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
John Martin
Pharma
Longtime Gilead captain John Martin has died
John Martin, Gilead's CEO for 20 years, spun the company into an antiviral powerhouse with lifesaving HIV and HCV drugs—and a $100 billion market cap.
Angus Liu
Mar 31, 2021 11:14am
Celgene veteran Fouse top pick for Gilead CEO: analyst
Jul 31, 2018 11:00am
Gilead's top execs Milligan and Martin stepping down
Jul 25, 2018 5:01pm
Gilead shelved safer HIV drugs to shield older drugs: lawsuit
May 9, 2018 12:03pm
How Kite got Gilead to boost its buyout price by 42%
Sep 8, 2017 10:33am
Gilead CEO's 2016 pay shrank as shares dove
Apr 13, 2017 11:53am
